CRYO CELL INTERNATIONAL INC

NYSE:CCEL

Services-Misc Health & Allied Services, NEC·OLDSMAR, FL

Summary Financials

Revenue

$23.1M

+9.7% YoY

FY 2017

Adj. EBITDA

$4.2M

18.0% margin

FY 2025

Net Income

$402,095

1.7% margin

FY 2025

EPS (Diluted)

$0.05

FY 2025

Stock Price

$3.18

+0.0%

2026-03-11

52W Range

$3.10 – $6.99

P/E Ratio

63.6x

Market Cap

$25.6M

Cash

$560,960

FY 2025

Total Debt

$1.6M

FY 2018

Net Debt

$1.0M

FY 2018

Enterprise Value

$26.6M

Debt / EBITDA

0.2x

FY 2017

EV / EBITDA

6.4x

Employees

—

Revenue

$23.1M

+9.7% YoY

FY 2017

Adj. EBITDA

$4.2M

18.0% margin

FY 2025

Net Income

$402,095

1.7% margin

FY 2025

EPS (Diluted)

$0.05

FY 2025

Stock Price

$3.18

+0.0%

2026-03-11

52W Range

$3.10 – $6.99

P/E Ratio

63.6x

Market Cap

$25.6M

Cash

$560,960

FY 2025

Total Debt

$1.6M

FY 2018

Net Debt

$1.0M

FY 2018

Enterprise Value

$26.6M

Debt / EBITDA

0.2x

FY 2017

EV / EBITDA

6.4x

Employees

—